The impact of ACE2 and co-factors on SARS-CoV-2 infection in colorectal cancer

Shuwei Li; Silu Chen; Qiuyuan Zhu; Shuai Ben; Fang Gao; Junyi Xin; Mulong Du; Haiyan Chu; Dongying Gu; Zhengdong Zhang; Meilin Wang

doi:10.1002/ctm2.967

The impact of ACE2 and co-factors on SARS-CoV-2 infection in colorectal cancer

Clin Transl Med. 2022 Jul;12(7):e967. doi: 10.1002/ctm2.967.

Authors

Shuwei Li^{1

2}, Silu Chen^{2

3}, Qiuyuan Zhu^{2

3}, Shuai Ben^{2

3}, Fang Gao^{2

3}, Junyi Xin^{2

3}, Mulong Du^{3

4}, Haiyan Chu^{1

2}, Dongying Gu⁵, Zhengdong Zhang^{2

3}, Meilin Wang^{1

2

3}

Affiliations

¹ Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
² Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
³ Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
⁴ Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
⁵ Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

No abstract available

Keywords: ACE2; SARS-CoV-2; colorectal cancer; susceptibility.

Publication types

Letter

MeSH terms

Angiotensin-Converting Enzyme 2
COVID-19*
Colorectal Neoplasms*
Humans
Peptidyl-Dipeptidase A
SARS-CoV-2

Substances

Peptidyl-Dipeptidase A
Angiotensin-Converting Enzyme 2